Call us toll-free

Synthesis of C-3' methyl taxotere (docetaxel).

ETLV 1ère: Activity 2: Hemisynthesis of Taxotere®

Approximate price

Pages:

275 Words

$19,50

Docetaxel Taxotere - Compound Libraries

AB - Background: The new cytostatic agent taxol has clearly demonstrated its effectiveness in ovarian cancer patients. The synthesis of drugs related to taxol could overcome its limited natural supply and may have additional benefits, such as greater efficacy or better solubility. Taxotere (RP 56976, NSC 628503) is such a compound. We investigated the drug for its antitumor activity in human ovarian cancer xenografts. Materials and methods: Five human ovarian cancer lines were selected with respect to differences in histological subtypes, growth rates and chemosensitivity to conventional cytostatic agents. Tumors were implanted as fragments s.c. into both flanks of female nude mice (Hsd: athymic nude-nu). Treatment was started in groups of 5-8 mice at the time mean tumor volume measured 50-150 mm3. Taxotere was injected i.v. weekly × 2. Drug efficacy was expressed as the maximum percentage of growth inhibition of treated tumors as compared to control tumors. Results: At the maximum tolerated dose of 15-20 mg/kg for weekly i.v. × 2 injections, taxotere induced a mean weight loss of 10%-15% of the initial weight within 2 weeks after the first injection. The maximum percentage of growth inhibition obtained was ≥ 50% in 4/5 lines and ≥90% in 3/5 lines. In 2 lines, taxotere appeared more effective than cisplatin, cyclophosphamide or doxorubicin, drugs studied previously at maximum tolerated doses in the same tumor lines. Conclusion: Our findings in human ovarian cancer xenografts hold promise for the efficacy of taxotere in this type of disease in the clinic.

Docetaxel (Taxotere) is an microtubule disassembly inhibitor with IC50 of a range of 0.31-100 ηM

N2 - Background: The new cytostatic agent taxol has clearly demonstrated its effectiveness in ovarian cancer patients. The synthesis of drugs related to taxol could overcome its limited natural supply and may have additional benefits, such as greater efficacy or better solubility. Taxotere (RP 56976, NSC 628503) is such a compound. We investigated the drug for its antitumor activity in human ovarian cancer xenografts. Materials and methods: Five human ovarian cancer lines were selected with respect to differences in histological subtypes, growth rates and chemosensitivity to conventional cytostatic agents. Tumors were implanted as fragments s.c. into both flanks of female nude mice (Hsd: athymic nude-nu). Treatment was started in groups of 5-8 mice at the time mean tumor volume measured 50-150 mm3. Taxotere was injected i.v. weekly × 2. Drug efficacy was expressed as the maximum percentage of growth inhibition of treated tumors as compared to control tumors. Results: At the maximum tolerated dose of 15-20 mg/kg for weekly i.v. × 2 injections, taxotere induced a mean weight loss of 10%-15% of the initial weight within 2 weeks after the first injection. The maximum percentage of growth inhibition obtained was ≥ 50% in 4/5 lines and ≥90% in 3/5 lines. In 2 lines, taxotere appeared more effective than cisplatin, cyclophosphamide or doxorubicin, drugs studied previously at maximum tolerated doses in the same tumor lines. Conclusion: Our findings in human ovarian cancer xenografts hold promise for the efficacy of taxotere in this type of disease in the clinic.

Paclitaxel is one of several cytoskeletal drugs that target tubulin

TY - JOUR. T1 - The first synthesis of a C-9 carbonyl modified baccatin III derivative and its conversion to novel taxol® and taxotere® analogues

Background: The new cytostatic agent taxol has clearly demonstrated its effectiveness in ovarian cancer patients. The synthesis of drugs related to taxol could overcome its limited natural supply and may have additional benefits, such as greater efficacy or better solubility. Taxotere (RP 56976, NSC 628503) is such a compound. We investigated the drug for its antitumor activity in human ovarian cancer xenografts. Materials and methods: Five human ovarian cancer lines were selected with respect to differences in histological subtypes, growth rates and chemosensitivity to conventional cytostatic agents. Tumors were implanted as fragments s.c. into both flanks of female nude mice (Hsd: athymic nude-nu). Treatment was started in groups of 5-8 mice at the time mean tumor volume measured 50-150 mm3. Taxotere was injected i.v. weekly × 2. Drug efficacy was expressed as the maximum percentage of growth inhibition of treated tumors as compared to control tumors. Results: At the maximum tolerated dose of 15-20 mg/kg for weekly i.v. × 2 injections, taxotere induced a mean weight loss of 10%-15% of the initial weight within 2 weeks after the first injection. The maximum percentage of growth inhibition obtained was ≥ 50% in 4/5 lines and ≥90% in 3/5 lines. In 2 lines, taxotere appeared more effective than cisplatin, cyclophosphamide or doxorubicin, drugs studied previously at maximum tolerated doses in the same tumor lines. Conclusion: Our findings in human ovarian cancer xenografts hold promise for the efficacy of taxotere in this type of disease in the clinic.

Docetaxel plus Prednisone or Mitoxantrone plus …

The Effect of the Aromatic Rings of Taxol on Biological Activity and Solution Conformation: Synthesis and Evaluation of Saturated Taxol and Taxotere Analogs

Abstract: The invention discloses a synthesis method of a novel Taxotere derivative and application thereof in preparation of anti-tumor medicine
Order now
  • Iwao Ojima, Distinguished Professor - Stony Brook …

    Docetaxel - Wikipedia

  • 21/11/2013 · Iwao Ojima, Distinguished Professor

    Paclitaxel - Wikipedia

  • Journal of Drug Targeting - Taylor & Francis

    Principles of Cancer Therapy

Order now
  • Kim

    "I have always been impressed by the quick turnaround and your thoroughness. Easily the most professional essay writing service on the web."

  • Paul

    "Your assistance and the first class service is much appreciated. My essay reads so well and without your help I'm sure I would have been marked down again on grammar and syntax."

  • Ellen

    "Thanks again for your excellent work with my assignments. No doubts you're true experts at what you do and very approachable."

  • Joyce

    "Very professional, cheap and friendly service. Thanks for writing two important essays for me, I wouldn't have written it myself because of the tight deadline."

  • Albert

    "Thanks for your cautious eye, attention to detail and overall superb service. Thanks to you, now I am confident that I can submit my term paper on time."

  • Mary

    "Thank you for the GREAT work you have done. Just wanted to tell that I'm very happy with my essay and will get back with more assignments soon."

Ready to tackle your homework?

Place an order